학술논문
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.
Document Type
Journal
Author
Finn, Richard S.; Kudo, Masatoshi; Kang, Yoon-Koo; Yen, Chia-Jui; Galle, Peter R.; Llovet, Josep; Assenat, Eric; Brandi, Giovanni; Lim, Ho Yeong; Pracht, Marc; Rau, Kun Ming; Merle, Philippe; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Shin, Dongbok; Gerken, Guido; Abada, Paolo; Hsu, Yanzhi; Zhu, Andrew X.
Source
Subject
Language
English
ISSN
15277755